LENZ
George Jeffrey P., LENZ's Director, spent $49.9K of their own money on 5,592 shares at $9, opening a brand-new position.
+$49.9K
5,592 sh @ $9
LENZ
LENZ Therapeutics, Inc.
SEC CIK 1815776
$6.34
−54.7% · 90 days
90-day buys
$365.6K
3 open-market
90-day sells
$0
0 open-market
Net insider flow
+$365.6K
Net buying
Filings shown
44
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at LENZ have bought a net $365.6K of stock (3 open-market buys vs 0 sells).
Largest recent trade: Versant Venture Capital Vi, L.p. sold $10.15M of LENZ, trimming their stake 22%.
Most active filer: Versant Venture Capital Vi, L.p., with 34 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for LENZ, newest firstLENZ
Schimmelpennink Evert B., LENZ's CEO, spent $251.4K of their own money on 28,089 shares at $9, growing their stake 57%.
+$251.4K
28,089 sh @ $9
LENZ
Chevallard Daniel R., LENZ's CFO, spent $64.3K of their own money on 7,500 shares at $9, growing their stake 139%.
+$64.3K
7,500 sh @ $9
LENZ
+$20.8K
10,000 sh @ $2
LENZ
−$108.4K
4,212 sh @ $26
Advertisement
LENZ
−$152.6K
5,788 sh @ $26
LENZ
Mccollum James W, LENZ's Director, spent $239.3K of their own money on 10,500 shares at $23, opening a brand-new position.
+$239.3K
10,500 sh @ $23
LENZ
Chevallard Daniel R., LENZ's CFO, spent $454 of their own money on 20 shares at $23, growing their stake 1%.
+$454
20 sh @ $23
LENZ
Chevallard Daniel R., LENZ's CFO, spent $49.6K of their own money on 2,178 shares at $23, growing their stake 68%.
+$49.6K
2,178 sh @ $23
LENZ
Versant Venture Capital Vi, L.p. sold $2.25M of LENZ, trimming their stake 4%.
−$2.25M
49,701 sh @ $45
LENZ
Versant Venture Capital Vi, L.p. sold $1.56M of LENZ, trimming their stake 4%.
−$1.56M
34,405 sh @ $45
LENZ
Versant Venture Capital Vi, L.p. sold $3.85M of LENZ, trimming their stake 7%.
−$3.85M
83,066 sh @ $46
LENZ
Versant Venture Capital Vi, L.p. sold $2.67M of LENZ, trimming their stake 7%.
−$2.67M
57,502 sh @ $46
LENZ
−$8.3K
177 sh @ $47
LENZ
−$5.8K
123 sh @ $47
LENZ
Versant Venture Capital Vi, L.p. sold $2.06M of LENZ, trimming their stake 4%.
−$2.06M
49,479 sh @ $42
LENZ
Versant Venture Capital Vi, L.p. sold $1.01M of LENZ, trimming their stake 3%.
−$1.01M
24,370 sh @ $42
LENZ
Versant Venture Capital Vi, L.p. sold $1.76M of LENZ, trimming their stake 3%.
−$1.76M
40,907 sh @ $43
LENZ
Versant Venture Capital Vi, L.p. sold $866.4K of LENZ, trimming their stake 2%.
−$866.4K
20,148 sh @ $43
LENZ
−$11.6K
268 sh @ $43
LENZ
−$5.7K
132 sh @ $43
LENZ
Versant Venture Capital Vi, L.p. sold $1.71M of LENZ, trimming their stake 3%.
−$1.71M
43,978 sh @ $39
LENZ
Versant Venture Capital Vi, L.p. sold $844.2K of LENZ, trimming their stake 2%.
−$844.2K
21,661 sh @ $39
LENZ
−$136.9K
3,465 sh @ $40
LENZ
−$67.4K
1,707 sh @ $40
LENZ
Versant Venture Capital Vi, L.p. sold $1.99M of LENZ, trimming their stake 4%.
−$1.99M
50,270 sh @ $40
LENZ
Versant Venture Capital Vi, L.p. sold $978.7K of LENZ, trimming their stake 3%.
−$978.7K
24,760 sh @ $40
LENZ
−$85.8K
2,149 sh @ $40
LENZ
−$42.2K
1,058 sh @ $40
LENZ
Versant Venture Capital Vi, L.p. sold $820.3K of LENZ, trimming their stake 1%.
−$820.3K
20,493 sh @ $40
Advertisement
About LENZ insider activity
This page tracks every recent Form 4 filed for LENZ Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is LENZ insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for LENZ Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.